These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17217378)

  • 41. Regulation of PSA secretion and survival signaling by calcium-independent phopholipase A(2)beta in prostate cancer cells.
    Nicotera TM; Schuster DP; Bourhim M; Chadha K; Klaich G; Corral DA
    Prostate; 2009 Sep; 69(12):1270-80. PubMed ID: 19475654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens.
    Furusato B; Shaheduzzaman S; Petrovics G; Dobi A; Seifert M; Ravindranath L; Nau ME; Werner T; Vahey M; McLeod DG; Srivastava S; Sesterhenn IA
    Prostate Cancer Prostatic Dis; 2008; 11(2):194-7. PubMed ID: 17768422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin receptor expression by human prostate cancers.
    Cox ME; Gleave ME; Zakikhani M; Bell RH; Piura E; Vickers E; Cunningham M; Larsson O; Fazli L; Pollak M
    Prostate; 2009 Jan; 69(1):33-40. PubMed ID: 18785179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma.
    Effert P; Beniers AJ; Tamimi Y; Handt S; Jakse G
    Anticancer Res; 2004; 24(5A):3057-63. PubMed ID: 15517916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
    Sørensen KD; Wild PJ; Mortezavi A; Adolf K; Tørring N; Heebøll S; Ulhøi BP; Ottosen P; Sulser T; Hermanns T; Moch H; Borre M; Ørntoft TF; Dyrskjøt L
    Clin Cancer Res; 2009 Feb; 15(4):1400-10. PubMed ID: 19228741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment.
    Sigala S; Bodei S; Missale C; Zani D; Simeone C; Cunico SC; Spano PF
    Mol Cell Endocrinol; 2008 Mar; 284(1-2):11-20. PubMed ID: 18280641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of inflammation and aging on macrophage inhibitory cytokine-1 gene expression in rat ventral prostate.
    Taniguchi S; Taoka R; Inui M; Sugimoto M; Kakehi Y
    Urology; 2009 Feb; 73(2):410-4. PubMed ID: 18929399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression.
    Fernández-Martínez AB; Collado B; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Mol Cell Endocrinol; 2007 May; 270(1-2):8-16. PubMed ID: 17434257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the RSL1-dependent conditional expression system in LNCaP prostate cancer cells and development of a single vector format.
    Lessard J; Aicha SB; Fournier A; Calvo E; Lavergne E; Pelletier M; Labrie C
    Prostate; 2007 Jun; 67(8):808-19. PubMed ID: 17373718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adipocyte culture medium stimulates production of macrophage inhibitory cytokine 1 in MDA-MB-231 cells.
    Kim JH; Kim KY; Jeon JH; Lee SH; Hwang JE; Lee JH; Kim KK; Lim JS; Kim KI; Moon EY; Lee HG; Ryu JH; Yang Y
    Cancer Lett; 2008 Mar; 261(2):253-62. PubMed ID: 18164124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcriptional regulation of the beta1C integrin splice variant in human prostate adenocarcinoma.
    Moro L; Greco M; Ditonno P; Battaglia M; Marra E; Perlino E
    Int J Oncol; 2003 Dec; 23(6):1601-6. PubMed ID: 14612932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer.
    Ho LL; Kench JG; Handelsman DJ; Scheffer GL; Stricker PD; Grygiel JG; Sutherland RL; Henshall SM; Allen JD; Horvath LG
    Prostate; 2008 Sep; 68(13):1421-9. PubMed ID: 18615486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-CAM1 expression: differential effects on morphology, differentiation state and suppression of human PC-3 prostate carcinoma cells.
    Comegys MM; Carreiro MP; Brown JF; Mazzacua A; Flanagan DL; Makarovskiy A; Lin SH; Hixson DC
    Oncogene; 1999 May; 18(21):3261-76. PubMed ID: 10359532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer.
    Bloch M; Ousingsawat J; Simon R; Schraml P; Gasser TC; Mihatsch MJ; Kunzelmann K; Bubendorf L
    Oncogene; 2007 Apr; 26(17):2525-34. PubMed ID: 17146446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot study.
    Gazi E; Dwyer J; Gardner P; Ghanbari-Siahkali A; Wade AP; Miyan J; Lockyer NP; Vickerman JC; Clarke NW; Shanks JH; Scott LJ; Hart CA; Brown M
    J Pathol; 2003 Sep; 201(1):99-108. PubMed ID: 12950022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancer.
    Rondinelli RH; Epner DE; Tricoli JV
    Prostate Cancer Prostatic Dis; 1997 Dec; 1(2):66-72. PubMed ID: 12496918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Auto-antibodies in prostate cancer: humoral immune response to antigenic determinants coded by the differentially expressed transcripts FLJ23438 and VAMP3.
    Pontes ER; Matos LC; da Silva EA; Xavier LS; Diaz BL; Small IA; Reis EM; Verjovski-Almeida S; Barcinski MA; Gimba ER
    Prostate; 2006 Oct; 66(14):1463-73. PubMed ID: 16897729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissue.
    Bründl J; Wallinger S; Breyer J; Weber F; Evert M; Georgopoulos NT; Rosenhammer B; Burger M; Otto W; Rubenwolf P
    BMC Urol; 2018 Sep; 18(1):75. PubMed ID: 30176851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression pattern of the novel gene EG-1 in cancer.
    Zhang L; Maul RS; Rao J; Apple S; Seligson D; Sartippour M; Rubio R; Brooks MN
    Clin Cancer Res; 2004 May; 10(10):3504-8. PubMed ID: 15161708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.